Therapeutic Advances in Medical Oncology

tamedoncol.bsky.social

21 September 2026 06:21

On #TAMO in 2025. . End-of-life care is crucial in pancreatic #cancer. In this French cohort, 41% of pts received high-intensity EOL care, while #palliativecare involvement was associated with lower care intensity. . 👉 buff.ly/PyI4jy2

Jen L, PhD

drjkyl.bsky.social

21 August 2026 05:55

Systemic therapy for gastroenteropancreatic neuroendocrine neoplasms: current landscape and future directions @tamedoncol.bsky.social @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #chemotherapy #cancertreatment #oncology #openaccess

Jen L, PhD

drjkyl.bsky.social

30 July 2026 06:27

Current and emerging therapies targeting cell surface antigens and epigenetics in extensive stage small cell lung cancer: primer for clinicians @tamedoncol.bsky.social @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #CAR-T #SCLC #cancertreatment #oncology #openaccess

Jon Lim, FRCP PhD

drjonlim.bsky.social

09 July 2026 00:58

A great collaboration 🙌 between our Thoracic Oncology, and Advanced Immunotherapy and Cell Therapy teams at The Christie 🐝 - driven by our stellar Senior Clinical Research Fellows Federico Monaca and Rachel Woodford. Available #OpenAccess in 𝘛𝘩𝘦𝘳 𝘈𝘥𝘷 𝘔𝘦𝘥 𝘖𝘯𝘤𝘰𝘭 👇 @christielibrary.bsky.social

Jen L, PhD

drjkyl.bsky.social

09 July 2026 00:57

Treatment options in platinum-refractory male germ cell cancers: current standards and future directions @tamedoncol.bsky.social @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #ADCs #cancertreatment #oncology #openaccess